Perimeter Solutions, Inc.
PRM NYSE Chemicals & Allied Products Financials FY2019βFY2025
What Perimeter Solutions, Inc. does
No business description yet.
- Legal name
- Perimeter Solutions, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001880319-26-000013
0001880319
Revenue and margins
Perimeter Solutions, Inc. had $653M of revenue in fiscal 2025, up 16.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $209M in fiscal 2025, 31.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Perimeter Solutions, Inc. returned $40.4M to shareholders in fiscal 2025, 19% of free cash flow. The diluted share count rose 3.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Perimeter Solutions, Inc. can carry it.
| Fiscal year end | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $22.5M | $127M | $52.8M | $198M | $326M |
| Debt incl. finance leases | $687M | $665M | $673M | $675M | $676M |
| Net debt / EBITDA | 5.1x | β | 3.9x | 7.7x | β |
| Debt / equity | 2.4x | 0.6x | 0.6x | 0.6x | 0.6x |
| Interest coverage | 1.7x | β | 2.3x | β0.1x | β5.1x |
| Current ratio | 4.0x | 4.2x | 4.6x | 6.3x | 3.2x |
| Quick ratio | 2.3x | 2.2x | 1.9x | 4.4x | 2.4x |
| Total assets | $1.1B | $2.5B | $2.3B | $2.4B | $2.7B |
| Total liabilities | $847M | $1.3B | $1.2B | $1.3B | $1.5B |
| Shareholders' equity | $291M | $1.1B | $1.2B | $1.2B | $1.1B |
| Net debt (β = net cash) | $665M | $539M | $620M | $476M | $350M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | β / 5 | 7 / 9 | 5 / 9 |
| Accruals ratio | β | β4.1% | 2.8% | β8.2% | β17.5% |
| Altman Z'' | β | 1.22 | 1.05 | 1.06 | 0.26 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $239M | $340M | β | $322M | $561M | $653M |
| Gross profit | $83.9M | $162M | β | $128M | $317M | $375M |
| Operating income | β$5.8M | $71.5M | β | $94.5M | β$3.8M | β$201M |
| Interest expense | $51.7M | $42.0M | β | $41.4M | $40.5M | $39.1M |
| Pretax income | β$59.7M | $34.7M | β | $61.6M | β$46.9M | β$236M |
| Income tax | β$17.7M | $10.5M | β | β$5.9M | β$41.0M | β$29.9M |
| Net income | β$42.0M | $24.2M | β | $67.5M | β$5.9M | β$206M |
| Diluted EPS | β$0.79 | $0.46 | β | $0.41 | β$0.04 | β$1.37 |
| Diluted shares | 0.05B | 0.05B | β | 0.17B | 0.15B | 0.15B |
| Cash flow | ||||||
| Cash from operations | β$0.3M | $70.8M | β | $0.2M | $188M | $238M |
| Capital expenditure | $8.9M | $7.5M | β | $9.4M | $15.5M | $29.6M |
| Free cash flow | β$9.2M | $63.3M | β | β$9.2M | $173M | $209M |
| Depreciation and amortization | $58.0M | $58.1M | β | $64.9M | $65.7M | $74.0M |
| Stock-based compensation | $0.0M | $0.0M | β | $1.6M | $12.8M | $16.6M |
| Acquisitions | $16.3M | $2.0M | β | β | β | β |
| Share buybacks | β | $0.0M | β | $64.1M | $14.4M | $40.4M |
| Dividends and buybacks | β | $0.0M | β | $64.1M | $14.4M | $40.4M |
| Balance sheet | ||||||
| Cash and short-term investments | $9.8M | $22.5M | $127M | $52.8M | $198M | $326M |
| Total debt | β | $687M | $665M | $666M | $668M | $669M |
| Finance lease liabilities | β | β | $0.0M | $6.1M | $6.7M | $6.4M |
| Current assets | β | $133M | $309M | $251M | $394M | $564M |
| Current liabilities | β | $32.9M | $74.2M | $55.1M | $62.5M | $175M |
| Inventory | β | $58.8M | $143M | $146M | $116M | $140M |
| Property and equipment, net | β | $48.2M | $58.8M | $59.4M | $64.8M | $85.1M |
| Goodwill | $473M | $482M | $1.0B | $1.0B | $1.0B | $1.1B |
| Intangible assets | β | $474M | $1.0B | $945M | $898M | $899M |
| Total assets | β | $1.1B | $2.5B | $2.3B | $2.4B | $2.7B |
| Total liabilities | β | $847M | $1.3B | $1.2B | $1.3B | $1.5B |
| Shareholders' equity | $262M | $291M | $1.1B | $1.2B | $1.2B | $1.1B |
| Margins | ||||||
| Gross margin | 35.1% | 47.7% | β | 39.8% | 56.5% | 57.5% |
| Operating margin | β2.4% | 21.0% | β | 29.3% | β0.7% | β30.8% |
| EBITDA margin | 21.8% | 38.2% | β | 49.5% | 11.0% | β19.4% |
| Net margin | β17.6% | 7.1% | β | 21.0% | β1.1% | β31.6% |
| FCF margin | β3.8% | 18.6% | β | β2.9% | 30.8% | 31.9% |
| Returns | ||||||
| Return on capital | β | 5.2% | β | 5.3% | β0.2% | β10.8% |
| Return on capital employed | β | 6.5% | β | 4.2% | β0.2% | β8.1% |
| Return on equity | β16.0% | 8.8% | β | 5.9% | β0.5% | β18.0% |
| Return on assets | β | 2.1% | β | 2.8% | β0.2% | β8.1% |
| Growth | ||||||
| Revenue growth | β | 41.9% | β | β | 74.2% | 16.4% |
| Net income growth | β | β | β | β | β108.8% | β |
| EPS growth | β | β | β | β | β109.8% | β |
| FCF growth | β | β | β | β | β | 20.7% |
| Share count change | β | 0.0% | β | β | β12.5% | 3.2% |
| Financial health | ||||||
| Net debt / EBITDA | β | 5.1x | β | 3.9x | 7.7x | β |
| Debt / equity | β | 2.4x | 0.6x | 0.6x | 0.6x | 0.6x |
| Interest coverage | β0.1x | 1.7x | β | 2.3x | β0.1x | β5.1x |
| Current ratio | β | 4.0x | 4.2x | 4.6x | 6.3x | 3.2x |
| Quick ratio | β | 2.3x | 2.2x | 1.9x | 4.4x | 2.4x |
| Capital allocation | ||||||
| Capex / revenue | 3.7% | 2.2% | β | 2.9% | 2.8% | 4.5% |
| Stock comp / revenue | 0.0% | 0.0% | β | 0.5% | 2.3% | 2.5% |
| Payouts / FCF | β | 0.0% | β | β | 8.3% | 19.4% |
| Quality scores | ||||||
| Piotroski F-score | β | β | β | β | 7.0 | 5.0 |
| Altman Z'' | β | 1.2 | β | 1.1 | 1.1 | 0.3 |
| Accruals ratio | β | β4.1% | β | 2.8% | β8.2% | β17.5% |
Source: SEC EDGAR XBRL filings (CIK 0001880319). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.